These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7946449)

  • 1. Cellular binding of carboranylalanine and some effects of boron neutron capture. Analysis of cultured melanoma B16 cells.
    Pettersson OA; Olsson P; Lindström P; Sjöberg S; Larsson BS; Carlsson J
    Acta Oncol; 1994; 33(6):685-91. PubMed ID: 7946449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration and binding of L- and D-carboranylalanine in human melanoma spheroids.
    Pettersson OA; Olsson P; Lindström P; Sjöberg S; Carlsson J
    Melanoma Res; 1993 Oct; 3(5):369-76. PubMed ID: 8292895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain.
    Iwakura M; Kondoh H; Hiratsuka J; Ehara K; Tamaki N; Mishima Y
    Pigment Cell Res; 2002 Feb; 15(1):67-75. PubMed ID: 11837459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
    Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
    Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma.
    Tsuboi T; Kondoh H; Hiratsuka J; Mishima Y
    Pigment Cell Res; 1998 Oct; 11(5):275-82. PubMed ID: 9877098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors.
    Barth RF; Grecula JC; Yang W; Rotaru JH; Nawrocky M; Gupta N; Albertson BJ; Ferketich AK; Moeschberger ML; Coderre JA; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):267-77. PubMed ID: 14697448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boron neutron capture therapy of anterior chamber melanoma with p-boronophenylalanine.
    Packer S; Coderre J; Saraf S; Fairchild R; Hansrote J; Perry H
    Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):395-403. PubMed ID: 1740371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
    Chandra S; Ahmad T; Barth RF; Kabalka GW
    J Microsc; 2014 Jun; 254(3):146-56. PubMed ID: 24684609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution of boron concentration on melanoma-bearing hamsters after administration of p-, m-, o-boronophenylalanine.
    Hiratsuka J; Yoshino K; Kondoh H; Imajo Y; Mishima Y
    Jpn J Cancer Res; 2000 Apr; 91(4):446-50. PubMed ID: 10804294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New carborane-based compounds for boron neutron capture therapy: binding and toxicity of ANC-1, DAC-1 and B-Et-11-OMe in cultured human glioma and mouse melanoma cells.
    Lindström P; Olsson P; Malmqvist J; Pettersson J; Lemmen P; Werner B; Sjöberg S; Olin A; Carlsson J
    Anticancer Drugs; 1994 Feb; 5(1):43-52. PubMed ID: 8186429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors.
    Gregoire V; Begg AC; Huiskamp R; Verrijk R; Bartelink H
    Radiother Oncol; 1993 Apr; 27(1):46-54. PubMed ID: 8327732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Borono-2-
    Ishiwata K
    Ann Nucl Med; 2019 Apr; 33(4):223-236. PubMed ID: 30820862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative biological effectiveness (RBE) of thermal neutron capture therapy of cultured B-16 melanoma cells preincubated with 10B-paraboronophenylalanine.
    Ichihashi M; Sasase A; Hiramoto T; Funasaka Y; Hatta S; Mishima Y; Kobayashi T; Fukuda H; Yoshino K
    Pigment Cell Res; 1989; 2(4):325-9. PubMed ID: 2798325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
    Liu L; Barth RF; Tjarks W; Soloway AH; Anisuzzaman AK
    Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental Studies of Boronophenylalanine ((10)BPA) Biodistribution for the Individual Application of Boron Neutron Capture Therapy (BNCT) for Malignant Melanoma Treatment.
    Carpano M; Perona M; Rodriguez C; Nievas S; Olivera M; Santa Cruz GA; Brandizzi D; Cabrini R; Pisarev M; Juvenal GJ; Dagrosa MA
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):344-52. PubMed ID: 26232853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of biological effectiveness of boron neutron capture therapy in primary and metastatic melanoma cell lines.
    Rossini AE; Dagrosa MA; Portu A; Saint Martin G; Thorp S; Casal M; Navarro A; Juvenal GJ; Pisarev MA
    Int J Radiat Biol; 2015 Jan; 91(1):81-9. PubMed ID: 25004948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent.
    Matalka KZ; Barth RF; Staubus AE; Moeschberger ML; Coderre JA
    Radiat Res; 1994 Jan; 137(1):44-51. PubMed ID: 8265787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.